Novacyt (OTC:NVYTF) launches its CE-Mark’d two-gene COVID-19 test molecular test in countries requiring a two-gene testing approach to detect the presence of SARS-CoV-2, including France, Belgium, Croatia, Poland and the UAE.
French reimbursement authorities have confirmed that the test will qualify for reimbursement there.
The company continues to sell its single-gene COVID-19 test.
https://seekingalpha.com/news/3611685-novacyt-launches-two-gene-covidminus-19-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.